331. Thrombotic Microangiopathies/Thrombocytopenias: Clinical and Epidemiological: Poster I

Injectable pentosan polysulfate A novel cause of heparin induced thrombocytopenia and stroke

Fixed duration preemptive rituximab maintenance over two years in recurrent thrombotic thrombocytopenic purpura with low ADAMTS13 A single center case series

Therapeutic plasma exchange and intravenous immunoglobulin facilitate safe heparin re exposure in acute heparin induced thrombocytopenia A five patient case series

Management of heparin induced thrombocytopenia in impella supported cardiac surgery A comprehensive four patient case series with novel anticoagulation strategies

Cva with undetectable ADAMTS13 without hemolysis An atypical presentation of thrombotic thrombocytopenic purpura TTP

Assessing the association between antiphospholipid syndrome and non melanoma skin cancers A case control study on the role of a chronic inflammatory condition

Thrombotic thrombocytopenic purpura related mortality trends among the United States population A retrospective study using the CDC wonder database

Patterns of antiphospholipid antibody positivity in a real world laboratory over two decades

Characterization and risk factors of anticoagulation related bleeding in patients with thrombotic antiphospholipid syndrome An analysis using a synthetic real world data platform

Splenectomy as a treatment for relapsed or refractory immune thrombotic thrombocytopenic purpura A systematic review

Association between sars cov 2 infection COVID 19 vaccines and immune thrombocytopenia in adults a nationwide population based study in France